{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:09:09Z","timestamp":1781240949289,"version":"3.54.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.acvd.2024.10.323","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T08:14:09Z","timestamp":1732176849000},"page":"63-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of conduction disease and arrhythmias in patients with cardiac amyloidosis: A position paper from the Working Group of Cardiac Pacing and Electrophysiology of the French Society of Cardiology"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8462-2218","authenticated-orcid":false,"given":"Nicolas","family":"Lellouche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7183-4278","authenticated-orcid":false,"given":"Pascal","family":"Defaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-1235","authenticated-orcid":false,"given":"Vincent","family":"Algalarrondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Gandjbakhch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-1658","authenticated-orcid":false,"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Champ-Rigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Delsarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8123-4842","authenticated-orcid":false,"given":"Fabrice","family":"Extramiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7227-3428","authenticated-orcid":false,"given":"Eloi","family":"Marijon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9350-2437","authenticated-orcid":false,"given":"Rodrigue","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Combes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2645-5445","authenticated-orcid":false,"given":"Jerome","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Ait Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7017-1495","authenticated-orcid":false,"given":"Carole","family":"Mette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-4983","authenticated-orcid":false,"given":"Olivier","family":"Piot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-7042","authenticated-orcid":false,"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Klug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3554-7714","authenticated-orcid":false,"given":"Charles","family":"Guenancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-9320","authenticated-orcid":false,"given":"Frederic","family":"Sacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4800-1841","authenticated-orcid":false,"given":"Philippe","family":"Maury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2024.10.323_bib0525","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.10.323_bib0530","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0535","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.19102\/icrm.2018.090301","article-title":"Arrhythmias in cardiac amyloidosis","volume":"9","author":"John","year":"2018","journal-title":"J Innov Card Rhythm Manag"},{"key":"10.1016\/j.acvd.2024.10.323_bib0540","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/13506129.2018.1430027","article-title":"Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis","volume":"25","author":"Henein","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2024.10.323_bib0545","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/ejhf.2650","article-title":"Atrial amyloidosis: mechanisms and clinical manifestations","volume":"24","author":"Vergaro","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2024.10.323_bib0550","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.amjcard.2021.07.028","article-title":"Management strategies for atrial fibrillation and flutter in patients with transthyretin cardiac amyloidosis","volume":"157","author":"Dale","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0555","doi-asserted-by":"crossref","first-page":"131346","DOI":"10.1016\/j.ijcard.2023.131346","article-title":"Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis","volume":"392","author":"Fumagalli","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0560","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacep.2023.11.015","article-title":"Prevalence and treatment of atrial fibrillation and flutter in cardiac amyloidosis","volume":"10","author":"Haslett","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0565","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1253\/circrep.CR-23-0022","article-title":"Prevalence and treatment of arrhythmias in patients with transthyretin and light-chain cardiac amyloidosis","volume":"5","author":"Miyamoto","year":"2023","journal-title":"Circ Rep"},{"key":"10.1016\/j.acvd.2024.10.323_bib0570","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.hrthm.2024.01.056","article-title":"Atrial electrofunctional predictors of incident atrial fibrillation in cardiac amyloidosis","volume":"21","author":"Sinigiani","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2024.10.323_bib0575","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of arrhythmias in cardiac amyloidosis","volume":"6","author":"Giancaterino","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0580","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/13506129.2019.1620724","article-title":"Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality","volume":"26","author":"Sanchis","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2024.10.323_bib0585","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.carpath.2006.01.005","article-title":"Patterns of isolated atrial amyloid: a study of 100 hearts on autopsy","volume":"15","author":"Steiner","year":"2006","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0590","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s10517-016-3324-3","article-title":"Isolated atrial amyloidosis in patients with various types of atrial fibrillation","volume":"160","author":"Sukhacheva","year":"2016","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.acvd.2024.10.323_bib0595","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2018.10.079","article-title":"Direct current cardioversion of atrial arrhythmias in adults with cardiac amyloidosis","volume":"73","author":"El-Am","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0600","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0033-0620(90)90017-V","article-title":"Clinical evaluation of left ventricular diastolic performance","volume":"32","author":"Little","year":"1990","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2024.10.323_bib0605","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","article-title":"Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies","volume":"6","author":"Donnellan","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0610","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2024.10.323_bib0615","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ehf2.12308","article-title":"Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience","volume":"5","author":"Mints","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.acvd.2024.10.323_bib0620","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.amjcard.2020.12.024","article-title":"Impact of arrhythmias on hospitalizations in patients with cardiac amyloidosis","volume":"143","author":"Thakkar","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0625","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.104.2.618","article-title":"Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis","volume":"104","author":"Pollak","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.acvd.2024.10.323_bib0630","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.10.323_bib0635","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","article-title":"Digoxin sensitivity in amyloid cardiomyopathy","volume":"63","author":"Rubinow","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.10.323_bib0640","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.amjcard.2020.07.034","article-title":"Digoxin use in cardiac amyloidosis","volume":"133","author":"Donnelly","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0645","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13506129.2018.1449744","article-title":"Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?","volume":"25","author":"Muchtar","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2024.10.323_bib0650","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.10.323_bib0655","doi-asserted-by":"crossref","first-page":"e0301753","DOI":"10.1371\/journal.pone.0301753","article-title":"Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart failure and mortality","volume":"19","author":"Maury","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.acvd.2024.10.323_bib0660","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC Multicenter Randomized Trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.10.323_bib0665","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMoa041018","article-title":"Catheter ablation for atrial fibrillation in congestive heart failure","volume":"351","author":"Hsu","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2024.10.323_bib0670","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2024.10.323_bib0675","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.hrthm.2015.09.016","article-title":"Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy","volume":"13","author":"Barbhaiya","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2024.10.323_bib0680","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/pace.13992","article-title":"Catheter ablation of atrial fibrillation in cardiac amyloidosis","volume":"43","author":"Black-Maier","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0685","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/europace\/euz314","article-title":"Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis","volume":"22","author":"Donnellan","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.acvd.2024.10.323_bib0690","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/jce.13046","article-title":"Catheter ablation for atrial arrhythmias in patients with cardiac amyloidosis","volume":"27","author":"Tan","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0695","article-title":"Efficacy and clinical outcomes of catheter ablation for atrial arrhythmia in cardiac amyloidosis","author":"Ang","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2024.10.323_bib0700","doi-asserted-by":"crossref","first-page":"euae155","DOI":"10.1093\/europace\/euae155","article-title":"Clinical outcomes of catheter ablation for atrial fibrillation, atrial flutter, and atrial tachycardia in wild-type transthyretin amyloid cardiomyopathy: a proposed treatment strategy for catheter ablation in each arrhythmia","volume":"26","author":"Kanazawa","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.acvd.2024.10.323_bib0705","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.10.323_bib0710","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/ehjci\/jead344","article-title":"Effects of tafamidis on the left ventricular and left atrial strain in patients with wild-type transthyretin cardiac amyloidosis","volume":"25","author":"Nishizawa","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2024.10.323_bib0715","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jacep.2022.11.005","article-title":"Tafamidis and incidence of atrial fibrillation in transthyretin amyloid cardiomyopathy","volume":"9","author":"Girvin","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0720","doi-asserted-by":"crossref","first-page":"oead026","DOI":"10.1093\/ehjopen\/oead026","article-title":"Adverse outcomes of atrial fibrillation ablation in heart failure patients with and without cardiac amyloidosis: a Nationwide Readmissions Database analysis (2015-2019)","volume":"3","author":"Ullah","year":"2023","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.acvd.2024.10.323_bib0725","doi-asserted-by":"crossref","first-page":"e029339","DOI":"10.1161\/JAHA.122.029339","article-title":"safety of catheter ablation therapy for atrial fibrillation in cardiac amyloidosis","volume":"12","author":"Alhassan","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2024.10.323_bib0730","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.10.323_bib0735","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0740","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1002\/ehf2.14082","article-title":"Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants","volume":"9","author":"Touboul","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.acvd.2024.10.323_bib0745","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/europace\/eur406","article-title":"Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey","volume":"14","author":"Pisters","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.acvd.2024.10.323_bib0750","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archinte.166.7.719","article-title":"Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials","volume":"166","author":"Lafuente-Lafuente","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.acvd.2024.10.323_bib0755","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","article-title":"Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress","volume":"94","author":"Brenner","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2024.10.323_bib0760","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.jacc.2019.02.078","article-title":"Predicting the unpredictable: how to score the risk of stroke in cardiac amyloidosis?","volume":"73","author":"Russo","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0765","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.10.323_bib0770","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.108.785014","article-title":"Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis","volume":"119","author":"Feng","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.10.323_bib0775","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2019.01.035","article-title":"High prevalence of intracardiac thrombi in cardiac amyloidosis","volume":"73","author":"Martinez-Naharro","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0780","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jacep.2019.10.013","article-title":"No association between CHADS-VASc Score and left atrial appendage thrombus in patients with transthyretin amyloidosis","volume":"5","author":"Donnellan","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0785","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ejhf.2566","article-title":"Systemic embolism in amyloid transthyretin cardiomyopathy","volume":"24","author":"Vilches","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2024.10.323_bib0790","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/13506129.2020.1798922","article-title":"Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation","volume":"28","author":"Cappelli","year":"2021","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2024.10.323_bib0795","unstructured":"Damy T, Lairez O, Algalarrondo V, Charron P. Protocole national de diagnostic et de soins (PNDS) des amyloses cardiaques\u00a0; Fili\u00e8re CARDIOGEN\u00a0; Centre de r\u00e9f\u00e9rence Amyloses Cardiaques 2020\u20132021. Available at: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-12\/pnds_amyloses_cardiaques_v20_version_finale_31082021.pdf."},{"key":"10.1016\/j.acvd.2024.10.323_bib0800","doi-asserted-by":"crossref","first-page":"742428","DOI":"10.3389\/fcvm.2021.742428","article-title":"New oral anticoagulants vs. vitamin K antagonists among patients with cardiac amyloidosis: prognostic impact","volume":"8","author":"Cariou","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.acvd.2024.10.323_bib0805","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.recesp.2022.07.011","article-title":"Cardiac amyloidosis and left atrial appendage closure. The CAMYLAAC study","volume":"76","author":"Amat-Santos","year":"2023","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.acvd.2024.10.323_bib0810","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00392-020-01651-8","article-title":"Clinical outcomes and thrombus resolution in patients with solid left atrial appendage thrombi: results of a single-center real-world registry","volume":"110","author":"Nelles","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0815","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amjcard.2018.09.027","article-title":"Prevalence and resolution of left atrial thrombus in patients with nonvalvular atrial fibrillation and flutter with oral anticoagulation","volume":"123","author":"Niku","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0820","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ahj.2016.05.007","article-title":"Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)","volume":"178","author":"Lip","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2024.10.323_bib0825","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/europace\/euz257","article-title":"Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey","volume":"22","author":"Farkowski","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.acvd.2024.10.323_bib0830","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4244\/EIJ-D-21-00713","article-title":"Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry","volume":"18","author":"Sebag","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2024.10.323_bib0835","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/circ.104.14.1594","article-title":"Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts","volume":"104","author":"Liao","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.10.323_bib0840","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2011.04.133","article-title":"Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs","volume":"410","author":"Bourgault","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.acvd.2024.10.323_bib0845","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaccao.2021.07.010","article-title":"Electrophysiological manifestations of cardiac amyloidosis: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Hartnett","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0850","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2003.08.043","article-title":"Noninvasive diagnosis of biopsy-proven cardiac amyloidosis","volume":"43","author":"Rahman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0855","doi-asserted-by":"crossref","first-page":"e006619","DOI":"10.1161\/CIRCHEARTFAILURE.119.006619","article-title":"Baseline ECG features and arrhythmic profile in transthyretin versus light chain cardiac amyloidosis","volume":"13","author":"Cappelli","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.acvd.2024.10.323_bib0860","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/anec.12032","article-title":"Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis","volume":"18","author":"Boldrini","year":"2013","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0865","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/13506129409148623","article-title":"Autonomic neuropathy in AL (primary) amyloidosis and its effect on survival","volume":"1","author":"Berg","year":"1994","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2024.10.323_bib0870","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/heart.88.6.615","article-title":"Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension?","volume":"88","author":"Bernardi","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2024.10.323_bib0875","first-page":"e13922","article-title":"A case report of sick sinus syndrome as an initial presentation of primary amyloidosis","volume":"13","author":"Abdelazeem","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.acvd.2024.10.323_bib0880","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0885","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.amjcard.2020.05.021","article-title":"Prevalence, incidence, and impact on mortality of conduction system disease in transthyretin cardiac amyloidosis","volume":"128","author":"Donnellan","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0890","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ehf2.14645","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients","volume":"11","author":"Aaseth","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.acvd.2024.10.323_bib0895","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13506129.2019.1625322","article-title":"Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders","volume":"26","author":"Lopez-Sainz","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2024.10.323_bib0900","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3\u00a0main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.10.323_bib0905","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jacep.2020.04.020","article-title":"Cardiac implantable electronic devices: a window into the evolution of conduction disease in cardiac amyloidosis","volume":"6","author":"Rehorn","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0910","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.hrthm.2012.02.033","article-title":"Prophylactic pacemaker implantation in familial amyloid polyneuropathy","volume":"9","author":"Algalarrondo","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2024.10.323_bib0915","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ejhf.2533","article-title":"Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis","volume":"24","author":"Porcari","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2024.10.323_bib0920","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.10.323_bib0925","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2024.10.323_bib0930","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1111\/jce.14180","article-title":"Cardiac devices in patients with transthyretin amyloidosis: Impact on functional class, left ventricular function, mitral regurgitation, and mortality","volume":"30","author":"Donnellan","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0935","article-title":"Predictive value of right ventricular sensing during cardiac device implantation to diagnose cardiac amyloidosis","author":"Hamon","year":"2024","journal-title":"JACC: Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa088","article-title":"Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy","volume":"4","author":"Aouate","year":"2020","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.acvd.2024.10.323_bib0945","doi-asserted-by":"crossref","first-page":"e017335","DOI":"10.1161\/JAHA.120.017335","article-title":"Cardiac resynchronization therapy for transthyretin cardiac amyloidosis","volume":"9","author":"Donnellan","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2024.10.323_bib0950","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ehf2.13663","article-title":"Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis","volume":"9","author":"Fischer","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.acvd.2024.10.323_bib0955","doi-asserted-by":"crossref","first-page":"1333484","DOI":"10.3389\/fcvm.2023.1333484","article-title":"Case report: left bundle branch pacing in an amyloid light-chain cardiac amyloidosis patient with atrioventricular block","volume":"10","author":"Yu","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.acvd.2024.10.323_bib0960","first-page":"182","article-title":"Initial experience with left bundle branch area pacing in patients with transthyretin cardiac amyloidosis","volume":"75","author":"Bermudez-Jimenez","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.acvd.2024.10.323_bib0965","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/pace.14894","article-title":"Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experience","volume":"47","author":"Pham-Trung","year":"2024","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0970","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2009.05.040","article-title":"Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring","volume":"104","author":"Goldsmith","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0975","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1460-9592.2001.01228.x","article-title":"Holter monitoring in AL amyloidosis: prognostic implications","volume":"24","author":"Palladini","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0980","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2024.10.323_bib0985","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/13506129.2021.2013193","article-title":"Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival","volume":"29","author":"Kharoubi","year":"2022","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2024.10.323_bib0990","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0735-1097(84)80436-2","article-title":"Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities","volume":"3","author":"Falk","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib0995","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/eurheartj\/ehu506","article-title":"A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis","volume":"36","author":"Sayed","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.10.323_bib1000","doi-asserted-by":"crossref","first-page":"100561","DOI":"10.1016\/j.jacadv.2023.100561","article-title":"Effect of defibrillator on all-cause mortality in patients with cardiac amyloidosis","volume":"2","author":"Al-Sadawi","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.acvd.2024.10.323_bib1005","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.10.323_bib1010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.acvd.2024.10.323_bib1015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jce.12123","article-title":"Implantable cardioverter defibrillators in patients with cardiac amyloidosis","volume":"24","author":"Lin","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib1020","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijcard.2016.07.254","article-title":"Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis","volume":"222","author":"Hamon","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib1025","doi-asserted-by":"crossref","first-page":"euad105","DOI":"10.1093\/europace\/euad105","article-title":"Clinical, electrocardiographic, and echocardiographic parameters associated with the development of pacing and implantable cardioverter-defibrillator indication in patients with transthyretin amyloid cardiomyopathy","volume":"25","author":"Kawahara","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.acvd.2024.10.323_bib1030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/pace.14458","article-title":"Ventricular arrhythmia burden and implantable cardioverter-defibrillator outcomes in transthyretin cardiac amyloidosis","volume":"45","author":"Brown","year":"2022","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib1035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2021.11.057","article-title":"Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid cardiomyopathy","volume":"349","author":"Dale","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2024.10.323_bib1040","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/europace\/euaa094","article-title":"Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator","volume":"22","author":"Kim","year":"2020","journal-title":"Europace"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213624006715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213624006715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T09:51:16Z","timestamp":1741686676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213624006715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1875213624006715"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2024.10.323","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of conduction disease and arrhythmias in patients with cardiac amyloidosis: A position paper from the Working Group of Cardiac Pacing and Electrophysiology of the French Society of Cardiology","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2024.10.323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}